Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_assertion type Assertion NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_head.
- NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_assertion description "[Therefore, we evaluated the feasibility of intracavitary injection of E1A gene complexed with DC-Chol cationic liposome (DCC-E1A) in patients with both HER-2/neu-overexpressing and low HER-2/neu-expressing breast and ovarian cancers in a phase I clinical trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_provenance.
- NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_assertion evidence source_evidence_literature NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_provenance.
- NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_assertion SIO_000772 11454891 NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_provenance.
- NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_assertion wasDerivedFrom befree-2016 NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_provenance.
- NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_assertion wasGeneratedBy ECO_0000203 NP324035.RAT0twd7x1Eh83JCuPm2sbL5FIzwaC8XAQVcVqEwnSaVg130_provenance.